Kristen Pierce
Chief Development OfficerDr. Kristen Pierce, Ph.D. serves as Chief Development Officer of CERo Therapeutics Inc since October 2024. Dr. Pierce is Chief Development Officer of CERo Therapeutics Holdings, Inc. from October 1, 2024. She has oncology experience, leading nonclinical and early clinical stage projects. Prior to joining CERo in March 2024, Dr. Pierce was Vice President, Translational Medicine at Pionyr Immunotherapeutics from September 2021 to June 2023. Prior to that, she served as Executive Director, Asset Team Leader at Pfizer Inc. where she led the late nonclinical and early clinical development of several antibody and small molecules in oncology. Dr. Pierce received her Ph.D. from the University of Arizona in Pharmacology and Toxicology and spent four years as a postdoc at Duke University in the laboratory of the Nobel Prize winning scientist, Dr. Robert J. Lefkowitz. Dr. Pierce received her B.A. from Bates College.
Positions
- Company NameCERo Therapeutics Holdings, Inc.Stock CodeCEROPositionChief Development OfficerRelated Securities
